Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?
暂无分享,去创建一个
[1] K. Toellner,et al. Versatility of stem and progenitor cells and the instructive actions of cytokines on hematopoiesis , 2015, Critical reviews in clinical laboratory sciences.
[2] Alba Rodriguez-Meira,et al. Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy. , 2015, Seminars in cancer biology.
[3] I. Sánchez-García. How tumour cell identity is established? , 2015, Seminars in cancer biology.
[4] A. Gentles,et al. Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages , 2015, Proceedings of the National Academy of Sciences.
[5] Ash A. Alizadeh,et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation , 2015, Proceedings of the National Academy of Sciences.
[6] D. Sahoo,et al. Identification and Specification of the Mouse Skeletal Stem Cell , 2015, Cell.
[7] K. Akashi,et al. The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell. , 2014, Experimental hematology.
[8] T. Miyamoto,et al. Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis , 2014, International Journal of Hematology.
[9] W. C. Chan,et al. Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma , 2014, Nature Communications.
[10] M. Berger,et al. Hematopoietic Stem Cell Origin of BRAFV600E Mutations in Hairy Cell Leukemia , 2014, Science Translational Medicine.
[11] O. Griffith,et al. Mitelman Database (Chromosome Aberrations and Gene Fusions in Cancer) , 2014 .
[12] Thomas J. Hudson,et al. Corrigendum: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia , 2014, Nature.
[13] A. Mead,et al. Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate , 2014, The Journal of experimental medicine.
[14] I. Lossos,et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas , 2014, Nature Genetics.
[15] O. Nureki,et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma , 2014, Nature Genetics.
[16] M. Calaminici,et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma , 2013, Nature Genetics.
[17] I. Macaulay,et al. Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy , 2013, Nature.
[18] T. Graf,et al. CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age. , 2013, Blood.
[19] I. Sánchez-García,et al. Function of oncogenes in cancer development: a changing paradigm , 2013, The EMBO journal.
[20] S. Nutt,et al. M-CSF instructs myeloid lineage fate in single haematopoietic stem cells , 2013, Nature.
[21] Paul Bertone,et al. Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner. , 2013, Genes & development.
[22] I. Sánchez-García,et al. p53 restoration kills primitive leukemia cells in vivo and increases survival of leukemic mice , 2013, Cell cycle.
[23] Ash A. Alizadeh,et al. Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation , 2012, Nature Communications.
[24] A. McKenna,et al. Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia , 2012, Cell.
[25] I. González-Herrero,et al. Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB , 2012, Cell Cycle.
[26] D. Weinstock,et al. The evolving contribution of hematopoietic progenitor cells to lymphomagenesis. , 2012, Blood.
[27] I. Weissman,et al. Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia , 2012, Science Translational Medicine.
[28] Diego Alonso-López,et al. A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors , 2012, The EMBO journal.
[29] P. Gaulard,et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. , 2012, Blood.
[30] Joshua F. McMichael,et al. The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.
[31] I. Lossos,et al. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice , 2012, Proceedings of the National Academy of Sciences.
[32] W. Carroll,et al. Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia. , 2012, Blood.
[33] José Alberola-lla,et al. CD86 is expressed on murine hematopoietic stem cells and denotes lymphopoietic potential. , 2012, Blood.
[34] Ken Chen,et al. Clonal architecture of secondary acute myeloid leukemia. , 2012, The New England journal of medicine.
[35] W. Chan,et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. , 2012, Blood.
[36] Christian Bastard,et al. TET2 and DNMT3A mutations in human T-cell lymphoma. , 2012, The New England journal of medicine.
[37] Joshua F. McMichael,et al. Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.
[38] E. Giné,et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia , 2011, Nature Genetics.
[39] A. Sivachenko,et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. , 2011, The New England journal of medicine.
[40] Konstantinos J. Mavrakis,et al. The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma , 2011, Cell.
[41] Lia S. Campos,et al. Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1 , 2011, Proceedings of the National Academy of Sciences.
[42] S. Sugano,et al. Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.
[43] K. Akashi,et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. , 2011, Cancer cell.
[44] Steven J. M. Jones,et al. Frequent mutation of histone modifying genes in non-Hodgkin lymphoma , 2011, Nature.
[45] P. Opolon,et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.
[46] Juliane C. Dohm,et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.
[47] Li Ding,et al. Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes , 2011, Leukemia.
[48] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[49] Raul Rabadan,et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma , 2010, Nature.
[50] Joelle M. Kalicki-Veizer,et al. Recurrent DNMT3A Mutations In Patients with Myelodysplastic Syndrome , 2010 .
[51] P. Hughes,et al. The versatility of haematopoietic stem cells: implications for leukaemia , 2010, Critical reviews in clinical laboratory sciences.
[52] P. Ye,et al. Oncogenic potential of retinoic acid receptor-gamma in hepatocellular carcinoma. , 2010, Cancer research.
[53] Nathan C Boles,et al. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. , 2010, Cell stem cell.
[54] Scott W. Lowe,et al. Stem cells: The promises and perils of p53 , 2009, Nature.
[55] S. Ogawa,et al. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms , 2009, Nature.
[56] Philipp S. Hoppe,et al. Hematopoietic Cytokines Can Instruct Lineage Choice , 2009, Science.
[57] S. Ogawa,et al. Frequent inactivation of A20 in B-cell lymphomas , 2009, Nature.
[58] I. Sánchez-García,et al. B‐cell acute lymphoblastic leukaemia: towards understanding its cellular origin , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.
[59] H. Kawamoto,et al. A new paradigm for hematopoietic cell lineages: revision of the classical concept of the myeloid-lymphoid dichotomy. , 2009, Trends in immunology.
[60] M. Pérez-Caro,et al. Stem-cell driven cancer: "Hands-off" regulation of cancer development , 2009, Cell cycle.
[61] Rhodri Ceredig,et al. Models of haematopoiesis: seeing the wood for the trees , 2009, Nature Reviews Immunology.
[62] M. Piris,et al. Cancer induction by restriction of oncogene expression to the stem cell compartment , 2008, The EMBO journal.
[63] Jan Delabie,et al. Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma , 2008, Science.
[64] K. Akashi,et al. The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. , 2007, Blood.
[65] M. Blagosklonny. Cancer stem cell and cancer stemloids: From biology to therapy , 2007, Cancer biology & therapy.
[66] Junia V. Melo,et al. Chronic myeloid leukaemia as a model of disease evolution in human cancer , 2007, Nature Reviews Cancer.
[67] T. Graf,et al. Early decisions in lymphoid development. , 2007, Current opinion in immunology.
[68] M. Blagosklonny. Target for cancer therapy: proliferating cells or stem cells , 2006, Leukemia.
[69] A. Rolink,et al. A B220+ CD117+ CD19± hematopoietic progenitor with potent lymphoid and myeloid developmental potential , 2005, European journal of immunology.
[70] Lina A. Thoren,et al. Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential A Revised Road Map for Adult Blood Lineage Commitment , 2005, Cell.
[71] A. Rolink,et al. The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential. , 2005, Blood.
[72] M. Bevan,et al. Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors. , 2005, Blood.
[73] L. Chin,et al. Nuclear cloning of embryonal carcinoma cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[74] Rudolf Jaenisch,et al. Reprogramming of a melanoma genome by nuclear transplantation. , 2004, Genes & development.
[75] Thomas M. Schmitt,et al. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. , 2004, Immunity.
[76] T. Curran,et al. Mouse embryos cloned from brain tumors. , 2003, Cancer research.
[77] Y. Katsura. Redefinition of lymphoid progenitors , 2002, Nature Reviews Immunology.
[78] I. Weissman,et al. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[79] I. Weissman,et al. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.
[80] H. Macdonald,et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. , 1999, Immunity.
[81] I. Weissman,et al. Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.
[82] K. Akashi,et al. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. , 1996, Blood.
[83] D. Metcalf. Lineage commitment of hemopoietic progenitor cells in developing blast cell colonies: influence of colony-stimulating factors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[84] M. Shankland. Differentiation of the O and P cell lines in the embryo of the leech. II. Genealogical relationship of descendant pattern elements in alternative developmental pathways. , 1987, Developmental biology.
[85] D. Metcalf,et al. Clonal analysis of progenitor cell commitment to granulocyte or macrophage production , 1982, Journal of cellular physiology.
[86] T. Papayannopoulou,et al. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. , 1977, The American journal of medicine.
[87] F. Mitelman,et al. Mitelman database of chromosome aberrations and gene fusions in cancer , 2014 .
[88] J. Salk. Clonal evolution in cancer , 2010 .
[89] I. Weissman,et al. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. , 2001, Annual review of cell and developmental biology.